Skip to menu Skip to content Skip to footer
Dr Moe Thuzar
Dr

Moe Thuzar

Email: 
Phone: 
+61 7 3176 2111

Overview

Background

Moe Thuzar (MBBS, FRCP UK, FRACP, PhD) is an Endocrinologist at the Princess Alexandra Hospital and a Research Fellow at the University of Queensland Diamantina Institute, Faculty of Medicine, University of Queensland, Brisbane. She has a strong research interest in the Neuroendocrine Regulation of Metabolism and Cardiovascular Health in Humans. After completing her specialist training and receiving FRACP (Fellowship of the Royal Australasian College of Physicians) in early 2014, she undertook her PhD study (2014-2018, UQ) investigating the role of adrenal neuroendocrine system in the regulation of human brown adipose tissue and energy metabolism under the primary supervision of Professor Ken Ho. Moe then joined the Endocrine Hypertension Unit of Professor Michael Stowasser at the UQDI, pursuing further research in Cardiovascular Endocrinology, in particular, elucidating the role of the mineralocorticoid system in the regulation of cardiometabolic health and its interplay with other systems in humans, and investigating optimal diagnostic and management strategies for primary aldosteronism.

She has received numerous awards for her work including US Endocrine Society’s Outstanding Abstract Award (2016) and Presidential Awards for Excellence in Cardiovascular Endocrinology Research (2017) and in Adipocyte Biology Research (2017), Early Career Researcher Award from the Australian & New Zealand Obesity Society (2016), Australasian Women in Endocrinology Young Investigator Award (2017), Queensland Health & Medical Research Award (Previously “Premier’s award”, finalist, 2017), Young Investigator Award, International Aldosterone Conference (runner-up, 2019). She is a Principal Investigator (PI) or Chief Investigator (CI) of a number of successful competitive grants, totalling ~4 millions to date, which include Royal Australasian College of Physicians-Australian Diabetes Society Research Establishment Fellowship (2023), MRFF Clinician Researchers Project Grant (CI, 2022-2025), Metro South Research Support Scheme Program Grant (PI, 2021-2023), Diabetes Australia Project Grant (PI, 2019-2021), Metro South Research Support Scheme Early Career Researcher Grant (PI, 2019-2022), High Blood Pressure Research Council of Australia International Travel Grant (2021), Endocrine Society of Australia Postdoctoral Fellowship (2019). She has served as an expert reviewer for Grant review panels including NHMRC Project Grants Scheme and for top journals in the field, and held editorial roles for a number of journals including the Frontiers in Endocrinology, Metabolites.

Availability

Dr Moe Thuzar is:
Available for supervision

Qualifications

  • Doctor of Philosophy, The University of Queensland

Works

Search Professor Moe Thuzar’s works on UQ eSpace

23 works between 2014 and 2024

1 - 20 of 23 works

2023

Journal Article

Editorial: Adrenal neuroendocrine system and cardiometabolic health: pathophysiology and clinical implications

Thuzar, Moe, Hannah-Shmouni, Fady and Stowasser, Michael (2023). Editorial: Adrenal neuroendocrine system and cardiometabolic health: pathophysiology and clinical implications. Frontiers in Endocrinology, 14 1295655, 1295655. doi: 10.3389/fendo.2023.1295655

Editorial: Adrenal neuroendocrine system and cardiometabolic health: pathophysiology and clinical implications

Featured

2022

Journal Article

Adrenal surgery for bilateral primary aldosteronism: an international retrospective cohort study

Williams, Tracy Ann, Gong, Siyuan, Tsurutani, Yuya, Tezuka, Yuta, Thuzar, Moe, Burrello, Jacopo, Wu, Vin-Cent, Yamazaki, Yuto, Mulatero, Paolo, Sasano, Hironobu, Stowasser, Michael, Nishikawa, Tetsuo, Satoh, Fumitoshi and Reincke, Martin (2022). Adrenal surgery for bilateral primary aldosteronism: an international retrospective cohort study. The Lancet Diabetes and Endocrinology, 10 (11), 769-771. doi: 10.1016/s2213-8587(22)00253-4

Adrenal surgery for bilateral primary aldosteronism: an international retrospective cohort study

Featured

2022

Journal Article

The metabolic phenotype of patients with primary aldosteronism: impact of subtype and sex – a multicenter-study of 3566 Caucasian and Asian subjects

Spyroglou, Ariadni, Handgriff, Laura, Müller, Lisa, Schwarzlmüller, Paul, Parasiliti-Caprino, Mirko, Fuss, Carmina Teresa, Remde, Hana, Hirsch, Anna, O’Toole, Samuel Matthew, Thuzar, Moe, Petramala, Luigi, Letizia, Claudio, Deflorenne, Elisa, Amar, Laurence, Vrckovnik, Rok, Kocjan, Tomaz, Zhang, Catherine D, Li, Dingfeng, Singh, Sumitabh, Katabami, Takuyuki, Yoneda, Takashi, Murakami, Masanori, Wada, Norio, Inagaki, Nobuya, Quinkler, Marcus, Ghigo, Ezio, Maccario, Mauro, Stowasser, Michael, Drake, William M ... Beuschlein, Felix (2022). The metabolic phenotype of patients with primary aldosteronism: impact of subtype and sex – a multicenter-study of 3566 Caucasian and Asian subjects. European Journal of Endocrinology, 187 (3), 361-372. doi: 10.1530/eje-22-0040

The metabolic phenotype of patients with primary aldosteronism: impact of subtype and sex – a multicenter-study of 3566 Caucasian and Asian subjects

Featured

2019

Journal Article

Diagnosis of primary aldosteronism by seated saline suppression test - variability between immunoassay and HPLC-MS/MS

Thuzar, Moe, Young, Karen, Ahmed, Ashraf H., Ward, Greg, Wolley, Martin, Guo, Zeng, Gordon, Richard D., McWhinney, Brett C., Ungerer, Jacobus P. and Stowasser, Michael (2019). Diagnosis of primary aldosteronism by seated saline suppression test - variability between immunoassay and HPLC-MS/MS. Journal of Clinical Endocrinology and Metabolism, 105 (3) dgz150, e477-e483. doi: 10.1210/clinem/dgz150

Diagnosis of primary aldosteronism by seated saline suppression test - variability between immunoassay and HPLC-MS/MS

Featured

2019

Journal Article

Mineralocorticoid antagonism enhances brown adipose tissue function in humans: a randomized placebo-controlled cross-over study

Thuzar, Moe, Law, W. Phillip, Dimeski, Goce, Stowasser, Michael and Ho, Ken K. Y. (2019). Mineralocorticoid antagonism enhances brown adipose tissue function in humans: a randomized placebo-controlled cross-over study. Diabetes, Obesity and Metabolism, 21 (3), 509-516. doi: 10.1111/dom.13539

Mineralocorticoid antagonism enhances brown adipose tissue function in humans: a randomized placebo-controlled cross-over study

Featured

2018

Journal Article

Glucocorticoids suppress brown adipose tissue function in humans: a double-blind placebo-controlled study

Thuzar, Moe, Law, W. Phillip, Ratnasingam, Jeyakantha, Jang, Christina, Dimeski, Goce and Ho, Ken KY (2018). Glucocorticoids suppress brown adipose tissue function in humans: a double-blind placebo-controlled study. Diabetes, Obesity and Metabolism, 20 (4), 840-848. doi: 10.1111/dom.13157

Glucocorticoids suppress brown adipose tissue function in humans: a double-blind placebo-controlled study

2024

Book Chapter

Myanmar’s Continuing Socio-economic Challenges since the Coup

Turnell, Sean and Thuzar, Moe (2024). Myanmar’s Continuing Socio-economic Challenges since the Coup. Southeast Asian Affairs 2024. (pp. 218-230) ISEAS–Yusof Ishak Institute Singapore. doi: 10.1355/9789815203516-014

Myanmar’s Continuing Socio-economic Challenges since the Coup

2022

Journal Article

High-intensity interval training is safe, feasible and efficacious in nonalcoholic steatohepatitis: a randomized controlled trial

Keating, Shelley E., Croci, Ilaria, Wallen, Matthew P., Cox, Emily R., Thuzar, Moe, Pham, Uyen, Mielke, Gregore I., Coombes, Jeff S., Macdonald, Graeme A. and Hickman, Ingrid J. (2022). High-intensity interval training is safe, feasible and efficacious in nonalcoholic steatohepatitis: a randomized controlled trial. Digestive Diseases and Sciences, 68 (5), 1-17. doi: 10.1007/s10620-022-07779-z

High-intensity interval training is safe, feasible and efficacious in nonalcoholic steatohepatitis: a randomized controlled trial

2022

Journal Article

Outcomes of a co-located approach for metabolic health care for people with schizophrenia

Siskind, Dan, Yen, Wesley, Thuzar, Moe, Russell, Anthony, Warren, Nicola, Kisely, Steve, Kar Ray, Manaan and Motamarri, Balaji (2022). Outcomes of a co-located approach for metabolic health care for people with schizophrenia. Australasian Psychiatry, 30 (4), 103985622210807-522. doi: 10.1177/10398562221080742

Outcomes of a co-located approach for metabolic health care for people with schizophrenia

2021

Journal Article

Obesity, metabolic syndrome, and inflammation: an update for anaesthetists caring for patients with obesity

Eley, Victoria A., Thuzar, Moe, Navarro, Séverine, Dodd, Benjamin R. and van Zundert, André A. (2021). Obesity, metabolic syndrome, and inflammation: an update for anaesthetists caring for patients with obesity. Anaesthesia Critical Care and Pain Medicine, 40 (6) 100947, 100947. doi: 10.1016/j.accpm.2021.100947

Obesity, metabolic syndrome, and inflammation: an update for anaesthetists caring for patients with obesity

2021

Journal Article

The mineralocorticoid receptor-an emerging player in metabolic syndrome?

Thuzar, Moe and Stowasser, Michael (2021). The mineralocorticoid receptor-an emerging player in metabolic syndrome?. Journal of Human Hypertension, 35 (2), 117-123. doi: 10.1038/s41371-020-00467-3

The mineralocorticoid receptor-an emerging player in metabolic syndrome?

2020

Journal Article

Biochemical, histopathological and genetic characterization of posture responsive and unresponsive APAs

Guo, Zeng, Nanba, Kazutaka, Udager, Aaron, McWhinney, Brett C., Ungerer, Jacobus P. J., Wolley, Martin, Thuzar, Moe, Gordon, Richard D., Rainey, William E. and Stowasser, Michael (2020). Biochemical, histopathological and genetic characterization of posture responsive and unresponsive APAs. Journal of Clinical Endocrinology and Metabolism, 105 (9), e3224-e3235. doi: 10.1210/clinem/dgaa367

Biochemical, histopathological and genetic characterization of posture responsive and unresponsive APAs

2020

Conference Publication

Relationship between the hypothalmic-pituitary-adrenocortical axis activity and the characteristics of aldosterone-producing adenomas

Thuzar, Moe, Lo, Yu-Chin, Guo, Zeng, Inder, Warrick J. and Stowasser, Michael (2020). Relationship between the hypothalmic-pituitary-adrenocortical axis activity and the characteristics of aldosterone-producing adenomas. 22nd European Congress of Endocrinology, Online, 5 - 9 September 2020. Bristol, United Kingdom: Bioscientifica. doi: 10.1530/endoabs.70.aep47

Relationship between the hypothalmic-pituitary-adrenocortical axis activity and the characteristics of aldosterone-producing adenomas

2020

Journal Article

Controversies and advances in adrenal venous sampling in the diagnostic workup of primary aldosteronism

Wolley, Martin, Thuzar, Moe and Stowasser, Michael (2020). Controversies and advances in adrenal venous sampling in the diagnostic workup of primary aldosteronism. Best Practice & Research Clinical Endocrinology & Metabolism, 34 (3) 101400, 101400. doi: 10.1016/j.beem.2020.101400

Controversies and advances in adrenal venous sampling in the diagnostic workup of primary aldosteronism

2019

Conference Publication

Defining the optimal cut-off plasma aldosterone level measured by immunoassay for the diagnosis of primary aldosteronism using seated salines suppression test

Thuzar, M., Young, K., Ahmed, A., Wolley, M., Guo, Z., Ward, G., McWhinney, B., Ungerer, J. and Stowasser, M. (2019). Defining the optimal cut-off plasma aldosterone level measured by immunoassay for the diagnosis of primary aldosteronism using seated salines suppression test. 29th European Meeting of Hypertension and Cardiovascular Protection of the European-Society-of-Hypertension (ESH), Milan, Italy, 21-24 June 2019. Philadelphia, PA United States: Lippincott Williams & Wilkins. doi: 10.1097/01.hjh.0000570272.55373.54

Defining the optimal cut-off plasma aldosterone level measured by immunoassay for the diagnosis of primary aldosteronism using seated salines suppression test

2018

Conference Publication

Effect of mineralocorticoid blockade on human brown fat-a randomised placebo-controlled cross-over study

Thuzar, Moe, Law, W. Phillip, Dimeski, Goce, Stowasser, Michael and Ho, Ken K. Y. (2018). Effect of mineralocorticoid blockade on human brown fat-a randomised placebo-controlled cross-over study. Joint Annual Scientific Meetings of Endocrine-Society-of-Australia (ESA) and Society-for-Reproductive-Biology (SRB), Perth Australia, Aug 27-30, 2017. HOBOKEN: WILEY.

Effect of mineralocorticoid blockade on human brown fat-a randomised placebo-controlled cross-over study

2018

Other Outputs

Regulation and metabolic significance of brown adipose tissue in humans

Thuzar, Moe (2018). Regulation and metabolic significance of brown adipose tissue in humans. PhD Thesis, Faculty of Medicine, The University of Queensland. doi: 10.14264/uql.2018.397

Regulation and metabolic significance of brown adipose tissue in humans

2018

Journal Article

An Adrenocortical Carcinoma Evolving From A Small Adrenal Incidentaloma After Years Of Latency

Thuzar, Moe, Perry-Keene, Donald A, d'Emden, Michael C and Duncan, Emma L (2018). An Adrenocortical Carcinoma Evolving From A Small Adrenal Incidentaloma After Years Of Latency. AACE Clinical Case Reports, 4 (1), e65-e69. doi: 10.4158/EP171931.CR

An Adrenocortical Carcinoma Evolving From A Small Adrenal Incidentaloma After Years Of Latency

2017

Conference Publication

Effect of formoterol, a selective beta(2)-adrenergic agonist, on brown adipose tissue function in humans: a double-blind placebo controlled study

Thuzar, Moe, Law, W. Phillip, Ratnasingam, Jeyakantha, Franklin, Michael, Dimeski, Goce and Ho, Ken K. Y. (2017). Effect of formoterol, a selective beta(2)-adrenergic agonist, on brown adipose tissue function in humans: a double-blind placebo controlled study. HOBOKEN: WILEY-BLACKWELL.

Effect of formoterol, a selective beta(2)-adrenergic agonist, on brown adipose tissue function in humans: a double-blind placebo controlled study

2016

Journal Article

MECHANISMS IN ENDOCRINOLOGY: brown adipose tissue in humans: regulation and metabolic significance

Thuzar, Moe and Ho, Ken K. Y. (2016). MECHANISMS IN ENDOCRINOLOGY: brown adipose tissue in humans: regulation and metabolic significance. European Journal of Endocrinology, 175 (1), R11-R25. doi: 10.1530/EJE-15-1217

MECHANISMS IN ENDOCRINOLOGY: brown adipose tissue in humans: regulation and metabolic significance

Funding

Past funding

  • 2019 - 2021
    Defining the Novel Effects of Mineralocorticoid Receptor Antagonism on Adiposity and Glucose Homeostatis - A Randomised Controlled Trial
    Diabetes Australia Research Program
    Open grant

Supervision

Availability

Dr Moe Thuzar is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Available projects

  • Defining the Novel Effects of Mineralocorticoid Receptor Antagonism on Metabolism in Humans

    This project involves a randomised clinical trial designed to investigate the potential novel metabolic benefits of Mineralocorticoid receptor (MR) antagonism and to elucidate the mechanistic changes underlying the metabolic benefits conferred by MR antagonism in humans.

    MRs are hormone receptors present in high abundance on fat cells of obese subjects. Metabolic syndrome is commonly found with mineralocorticoid hormone excess (primary hyperaldosteronism) and in the general population, mineralocorticoid level is predictive of obesity and metabolic diseases. There is strong evidence in animals that blocking MRs (MR antagonism) protects against obesity and metabolic complications. It is not known if similar mechanisms operate in humans.

    This project will help define the novel therapeutic potential of MR antagonists for management of obesity and metabolic diseases in overweight/obese humans. The results may also offer unique physiological insights into the underlying mechanisms modulating metabolic health for future research and development.

  • Mineralocorticoid Receptor Antagonist To Counteract Cardiometabolic Adverse Effects of Steroids/Glucocorticoids

    Metabolic syndrome and cardiovascular diseases are common side effects of steroids/glucocorticoids such as prednisolone, widely used for inflammatory diseases; there is no specific agent to counteract these adverse effects. There is evidence that these side effects are likely mediated by closely-related hormone receptors called mineralocorticoid receptors (MRs), present in fat and cardiac tissues and immune cells. We have previously discovered in healthy humans that MR antagonists exert opposing effects to those of glucocorticoids on adipose tissue metabolism.

    This project will examine if blocking the MRs by spironolactone can counteract metabolic and cardiac side effects without compromising beneficial antiinflammatory effects in people requiring prednisolone.

Supervision history

Current supervision

  • Doctor Philosophy

    Defining The Role Of Mineralocorticoid Receptor In Cardiometabolic Health & Inflammation & Optimising The Diagnostic Approach For Aldosterone-producing Adenoma

    Associate Advisor

    Other advisors: Professor Michael Stowasser

Media

Enquiries

For media enquiries about Dr Moe Thuzar's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au